[HTML][HTML] Lessons from the cancer genome
LA Garraway, ES Lander - Cell, 2013 - cell.com
Systematic studies of the cancer genome have exploded in recent years. These studies
have revealed scores of new cancer genes, including many in processes not previously …
have revealed scores of new cancer genes, including many in processes not previously …
Emerging patterns of somatic mutations in cancer
IR Watson, K Takahashi, PA Futreal, L Chin - Nature Reviews Genetics, 2013 - nature.com
Recent advances in technological tools for massively parallel, high-throughput sequencing
of DNA have enabled the comprehensive characterization of somatic mutations in a large …
of DNA have enabled the comprehensive characterization of somatic mutations in a large …
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
MT McCabe, HM Ott, G Ganji, S Korenchuk… - Nature, 2012 - nature.com
In eukaryotes, post-translational modification of histones is critical for regulation of chromatin
structure and gene expression. EZH2 is the catalytic subunit of the polycomb repressive …
structure and gene expression. EZH2 is the catalytic subunit of the polycomb repressive …
Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)
Trimethylation of histone H3 on lysine 27 (H3K27me3) is a repressive posttranslational
modification mediated by the histone methyltransferase EZH2. EZH2 is a component of the …
modification mediated by the histone methyltransferase EZH2. EZH2 is a component of the …
Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner
Recent studies point to a pivotal role of Polycomb repressive complex 2 (PRC2) in stem cell
function and cancer. Loss-of-function approaches targeting individual PRC2 subunits have …
function and cancer. Loss-of-function approaches targeting individual PRC2 subunits have …
New mutations and pathogenesis of myeloproliferative neoplasms
W Vainchenker, F Delhommeau… - Blood, The Journal …, 2011 - ashpublications.org
Myeloproliferative neoplasms (MPNs) are clonal disorders characterized by excessive
production of mature blood cells. In the majority of classic MPN—polycythemia vera …
production of mature blood cells. In the majority of classic MPN—polycythemia vera …
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
H Makishima, V Visconte, H Sakaguchi… - Blood, The Journal …, 2012 - ashpublications.org
Myelodysplastic syndromes (MDSs) are chronic and often progressive myeloid neoplasms
associated with remarkable heterogeneity in the histomorphology and clinical course …
associated with remarkable heterogeneity in the histomorphology and clinical course …
Unraveling the molecular pathophysiology of myelodysplastic syndromes
R Bejar, R Levine, BL Ebert - Journal of clinical oncology, 2011 - ascopubs.org
Somatically acquired genetic abnormalities lead to the salient features that define
myelodysplastic syndromes (MDS): clonal hematopoiesis, aberrant differentiation …
myelodysplastic syndromes (MDS): clonal hematopoiesis, aberrant differentiation …
Mutations in EZH2 cause Weaver syndrome
We used trio-based whole-exome sequencing to analyze two families affected by Weaver
syndrome, including one of the original families reported in 1974. Filtering of rare variants in …
syndrome, including one of the original families reported in 1974. Filtering of rare variants in …
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A
AM Jankowska, H Makishima, RV Tiu… - Blood, The Journal …, 2011 - ashpublications.org
Chronic myelomonocytic leukemia (CMML), a myelodysplastic/myeloproliferative neoplasm,
is characterized by monocytic proliferation, dysplasia, and progression to acute myeloid …
is characterized by monocytic proliferation, dysplasia, and progression to acute myeloid …